NEXTCURE INC. - COMMON STOCK

NextCure Publishes Preclinical Data Demonstrating Function of FLRT3 as a T Cell Inhibitor in Science Advances

05 3 2024 08:05:00 提供 Nasdaq GlobeNewswire

NextCure Presents Preclinical Data on a Novel Therapeutic Candidate Targeting VSTM-1 for the Treatment of Progressive Inflammatory Airway Disorders

18 1 2024 16:05:00 提供 Nasdaq GlobeNewswire

NextCure Publishes Non-Clinical Data Demonstrating Anti-Siglec-15 Treatment Prevented Bone Loss Due to Immobilization from Acute Spinal Cord Injury

21 12 2023 07:05:00 提供 Nasdaq GlobeNewswire

NextCure Provides Year-End Clinical Pipeline Updates

14 12 2023 06:45:00 提供 Nasdaq GlobeNewswire

NextCure to Present at the 35th Annual Piper Sandler Healthcare Conference

20 11 2023 07:00:00 提供 Nasdaq GlobeNewswire

NextCure Publishes Non-Clinical Data Defining the Mechanism of Action for NC525, a Novel LAIR-1 Antibody for AML

15 11 2023 16:05:00 提供 Nasdaq GlobeNewswire

NextCure Provides Business Update and Reports Third Quarter 2023 Financial Results

02 11 2023 16:05:00 提供 Nasdaq GlobeNewswire

Preclinical Data Demonstrate Anti-Siglec-15 Treatment Reduced Bone Loss and Enhanced Bone Quality in Mice with Moderate-to-Severe Osteogenesis Imperfecta (OI)

17 10 2023 08:05:00 提供 Nasdaq GlobeNewswire

NextCure Presents Preclinical Data on NC181, a Novel Therapeutic Candidate Targeting ApoE4, for the Treatment of Alzheimer’s Disease

26 9 2023 16:05:00 提供 Nasdaq GlobeNewswire

A Phase 2 Study of Anti-Siglec-15 Antibody, NC318, in Combination with Pembrolizumab (NCT04699123) Demonstrates Clinical Activity in Patients with Advanced PD-1 Axis Inhibitor Refractory NSCLC

12 9 2023 08:05:00 提供 Nasdaq GlobeNewswire

NextCure and Nordic Bioscience Publish Review Article on the Regulation of Tumor Immunity by Tumor Collagen

07 9 2023 16:05:00 提供 Nasdaq GlobeNewswire

Preclinical Data Demonstrate Potential Application of Anti-Siglec-15 Treatment in Bone Disease

05 9 2023 16:05:00 提供 Nasdaq GlobeNewswire

NextCure to Present at the H.C. Wainwright 25th Annual Global Investment Conference

31 8 2023 07:00:00 提供 Nasdaq GlobeNewswire

NextCure Provides Business Update and Reports Second Quarter 2023 Financial Results

03 8 2023 16:05:01 提供 Nasdaq GlobeNewswire

NextCure Presents Non-Clinical Data Defining the Mechanism of NC525 at the 2023 Federation of Clinical Immunology Societies (FOCIS) Annual Meeting

21 6 2023 16:05:00 提供 Nasdaq GlobeNewswire

NextCure to Present at the JMP Securities Life Sciences Conference

09 5 2023 07:00:01 提供 Nasdaq GlobeNewswire

NextCure Provides Business Update and Reports First Quarter 2023 Financial Results

04 5 2023 16:05:02 提供 Nasdaq GlobeNewswire

NextCure to Present at 22nd Annual Needham Virtual Healthcare Conference

11 4 2023 07:00:00 提供 Nasdaq GlobeNewswire

NextCure Provides Business Update and Reports Full Year 2022 Financial Results

02 3 2023 16:05:00 提供 Nasdaq GlobeNewswire

NextCure to Present at SVB Securities Global Biopharma Conference

07 2 2023 07:00:01 提供 Nasdaq GlobeNewswire